← Leaderboards
Cyril Henri Benes
University Of Tx Md Anderson Can Ctr
$1,568,505
Attributed
$2,134,639
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $820.8K · FY2016–20$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,134,639 · 2
By mechanism
U01$1,132,269 · 1
P01$1,002,370 · 1
Top collaborators
- Henning Willers2 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Heath Devin Skinner$8,539,031
- Katherine Arnold Hutcheson$5,107,957
- Hoda J. Badr$6,550,695
- Guojun Li$2,468,355
- Mitchell J. Frederick$5,632,139
Others in their field
Top investigators on “Inhibitor/Antagonist”
- John M Lachin · George Washington University$117,867,649
- David M Nathan · Massachusetts Institute Of Technology$117,867,649
- Randall J Bateman · Washington University$110,978,751
- David Heimbrook · Leidos Biomedical Research, Inc.$72,139,282
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Walter John Curran · Thomas Jefferson University$32,790,605
Research focus
Inhibitor/AntagonistMassachusettsDrug TargetingHigh Throughput ScreeningIn Vivo ModelMalignant NeoplasmsClinical TrialsDrug SensitivityGeneral HospitalsGrowthIn VitroIn VivoBaseKras2 GeneCancer CenterBiological MarkersDrug CombinationsCandidate MarkerEvaluationCell LineCellsClinically RelevantCollectionPharmaceutical Preparations
Grant awards (7)
Core B: Preclinical Therapeutics Core$232,061
P01 · FY2020 · CA · contact PI
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers$549,080
U01 · FY2019 · CA
Core B: Preclinical Therapeutics Core$229,657
P01 · FY2019 · CA · contact PI
High-Throughput Screening and Validation of Molecular Targeted Chemoradiosensitizers$583,189
U01 · FY2018 · CA
Core B: Preclinical Therapeutics Core$237,597
P01 · FY2018 · CA · contact PI
Core B: Preclinical Therapeutics Core$96,117
P01 · FY2017 · CA · contact PI
Core B: Preclinical Therapeutics Core$206,938
P01 · FY2016 · CA · contact PI